The association of age-related maculopathy susceptibility 2 gene polymorphisms with the 12 months outcomes of combination therapy with intravitreal aflibercept and verteporfin photodynamic therapy for polypoidal choroidal vasculopathy

Nakai Shunichiro; Honda Shigeru; Matsumiya Wataru; Miki Akiko; Nakamura Makoto

首页> 外文期刊>Investigative ophthalmology & visual science >The association of age-related maculopathy susceptibility 2 gene polymorphisms with the 12 months outcomes of combination therapy with intravitreal aflibercept and verteporfin photodynamic therapy for polypoidal choroidal vasculopathy

【24h】

The association of age-related maculopathy susceptibility 2 gene polymorphisms with the 12 months outcomes of combination therapy with intravitreal aflibercept and verteporfin photodynamic therapy for polypoidal choroidal vasculopathy

机译：年龄相关的小疗法易感性2基因多态性与脊髓灰质脉络膜血管病变术治疗的12个月结合治疗和Verteporfin光动力学治疗

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Investigative ophthalmology & visual science》 |2018年第9期|共2页
作者
Nakai Shunichiro; Honda Shigeru; Matsumiya Wataru; Miki Akiko; Nakamura Makoto;
展开▼
作者单位

Kobe Univ Grad Sch Med Kobe Hyogo Japan;

Kobe Univ Grad Sch Med Kobe Hyogo Japan;

Kobe Univ Grad Sch Med Kobe Hyogo Japan;

Kobe Univ Grad Sch Med Kobe Hyogo Japan;

Kobe Univ Grad Sch Med Kobe Hyogo Japan;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类眼科学;
关键词

相似文献

外文文献
中文文献
专利

1. The association of age-related maculopathy susceptibility 2 gene polymorphisms with the 12 months outcomes of combination therapy with intravitreal aflibercept and verteporfin photodynamic therapy for polypoidal choroidal vasculopathy [J] . Nakai Shunichiro, Honda Shigeru, Matsumiya Wataru, Investigative ophthalmology & visual science . 2018,第9期

机译：年龄相关的小疗法易感性2基因多态性与脊髓灰质脉络膜血管病变术治疗的12个月结合治疗和Verteporfin光动力学治疗
2. The association of age-related maculopathy susceptibility 2 gene polymorphisms with the 12 months outcomes of combination therapy with intravitreal aflibercept and verteporfin photodynamic therapy for polypoidal choroidal vasculopathy [J] . Nakai Shunichiro, Honda Shigeru, Matsumiya Wataru, Investigative ophthalmology & visual science . 2018,第9期

机译：年龄相关的小疗法易感性2基因多态性与脊髓灰质脉络膜血管病变术治疗的12个月结合治疗和Verteporfin光动力学治疗
3. Association of an age-related maculopathy susceptibility 2 gene variant with the 12-month outcomes of intravitreal aflibercept combined with photodynamic therapy for polypoidal choroidal vasculopathy [J] . Nakai Shunichiro, Matsumiya Wataru, Miki Akiko, Japanese Journal of Ophthalmology . 2019,第5期

机译：与年龄相关的小型疗法易感性2基因变体与玻璃体内术治疗脊髓灰质脉络膜血管病变的光动力疗法相结合的12个月结果
4. Association of GST Gene Polymorphism with Susceptibility to Leukemia in Punjabi Population and Differential Chemotherapy Response [C] . Shruti Caplash, Devinder S. Shu Molecular Medicine TRI-CON. . 2014

机译：GST基因多态性与白血病人群白血病易感性和差异化疗反应的关联
5. Genetic Investigation of Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy. [D] . Liu, Ke. 2013

机译：年龄相关性黄斑变性和息肉样脉络膜血管病的遗传学研究。
6. Efficacy and safety of ranibizumab monotherapy versus ranibizumab in combination with verteporfin photodynamic therapy in patients with polypoidal choroidal vasculopathy: 12-month outcomes in the Japanese cohort of EVEREST II study [O] . Kanji Takahashi, Masahito Ohji, Hiroko Terasaki, 2018

机译：雷尼单抗单药治疗与雷尼单抗联合维替泊芬光动力治疗在多形脉络膜脉管炎患者中的疗效和安全性：日本EVEREST II研究队列的12个月结果
7. One-year outcome of combination therapy with intravitreal aflibercept and photodynamic therapy for polypoidal choroidal vasculopathy [O] . Hsin-Yu Weng, Tzu-Lun Huang, Pei-Yao Chang, 2019

机译：脊髓灰质脉络膜血管病变术治疗和光动力学治疗组合治疗的一年结果

The association of age-related maculopathy susceptibility 2 gene polymorphisms with the 12 months outcomes of combination therapy with intravitreal aflibercept and verteporfin photodynamic therapy for polypoidal choroidal vasculopathy

著录项

引文网络

相似文献

相关主题

期刊订阅